1 in 4 patients may relapse on rituximab maintenance, study finds
About a quarter of people with granulomatosis with polyangiitis (GPA) or microscopic polyangiitis (MPA) under maintenance treatment with rituximab experience relapses, mainly during the first two years. That’s according to a real-world study in Greece that looked at data from 101 people with GPA or MPA, the two most common…